Published in Clin Infect Dis on February 01, 1996
Infective endocarditis epidemiology over five decades: a systematic review. PLoS One (2013) 1.66
Mortality from infective endocarditis: clinical predictors of outcome. Heart (2002) 1.59
Infective endocarditis: clinical spectrum, presentation and outcome. An analysis of 212 cases 1980-1995. Heart (2000) 1.58
Blood culture negative endocarditis: analysis of 63 cases presenting over 25 years. Heart (2003) 1.55
Accuracy and potential usefulness of triplex real-time PCR for improving antibiotic treatment of patients with blood cultures showing clustered gram-positive cocci on direct smears. J Clin Microbiol (2008) 1.29
Infective endocarditis in a Finnish teaching hospital: a study on 326 episodes treated during 1980-2004. Heart (2006) 1.17
Long term outcome of infective endocarditis in patients who were not drug addicts: a 10 year study. Heart (2000) 1.09
Hospital acquired native valve endocarditis: analysis of 22 cases presenting over 11 years. Heart (1998) 1.05
Infective endocarditis: determinants of long term outcome. Heart (2002) 1.04
Nonculture Laboratory Methods for the Diagnosis of Infectious Endocarditis. Curr Infect Dis Rep (1999) 1.03
Surgery in current therapy for infective endocarditis. Vasc Health Risk Manag (2011) 0.97
Assessment of safety of lactobacillus strains based on resistance to host innate defense mechanisms. Clin Diagn Lab Immunol (2003) 0.92
Awareness of infective endocarditis prophylaxis in parents of children with congenital heart disease: A prospective survey. Ann Pediatr Cardiol (2008) 0.91
Unusual extracardiac manifestations of isolated native tricuspid valve endocarditis. BMJ Case Rep (2010) 0.89
Solution insights into the structure of the Efb/C3 complement inhibitory complex as revealed by lysine acetylation and mass spectrometry. J Am Soc Mass Spectrom (2008) 0.89
Glucosyltransferases of viridans streptococci are modulins of interleukin-6 induction in infective endocarditis. Infect Immun (2005) 0.88
Cardiobacterium hominis endocarditis: A case report and review of the literature. Can J Infect Dis Med Microbiol (2005) 0.86
Isolated native tricuspid valve endocarditis caused by viridans streptococcus. Can J Infect Dis (2001) 0.85
Clinical features and outcome of infective endocarditis in yemeni patients treated with empirical antibiotic therapy. Heart Views (2010) 0.84
Broad-host-range shuttle vectors for screening of regulated promoter activity in viridans group streptococci: isolation of a pH-regulated promoter. Appl Environ Microbiol (2000) 0.83
Interleukin 1alpha increases the susceptibility of rabbits to experimental viridans streptococcal endocarditis. Infect Immun (2006) 0.80
Clinical features of right-sided infective endocarditis occurring in non-drug users. J Korean Med Sci (2014) 0.78
Issues in the Management of Endocarditis Caused by Resistant Gram-positive Organisms. Curr Infect Dis Rep (2004) 0.77
The bacteremia of dental origin and its implications in the appearance of bacterial endocarditis. Med Oral Patol Oral Cir Bucal (2014) 0.76
Therapeutic effect of ME1036 on endocarditis experimentally induced by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2005) 0.76
Risk and outcomes of aortic valve endocarditis among patients with bicuspid and tricuspid aortic valves. Open Heart (2017) 0.75
The clinical impacts of apparent embolic event and the predictors of in-hospital mortality in patients with infective endocarditis. J Korean Med Sci (2014) 0.75
Platelet depletion and severity of streptococcal endocarditis. Can J Infect Dis (1998) 0.75
Classic Peripheral Signs of Subacute Bacterial Endocarditis. Korean J Thorac Cardiovasc Surg (2016) 0.75
Infective endocarditis in pregnancy: Case report and review of the literature. Obstet Med (2015) 0.75
Infective endocarditis and perivalvular abscess: a dangerous duo. CMAJ (2002) 0.75
An assessment of the current diagnostic criteria for infective endocarditis. Can J Infect Dis (1998) 0.75
Epidemiological and clinical features, ultrasound findings and prognosis of right-sided infective endocarditis in a teaching hospital in Ouagadougou. Cardiovasc J Afr (2013) 0.75
Mitral valve endocarditis leading to acute myocardial and cerebellar infarction in a young adult. Clin Res Cardiol (2006) 0.75
The causative agents in infective endocarditis: a systematic review comprising 33,214 cases. Eur J Clin Microbiol Infect Dis (2016) 0.75
Eikenella corrodens infective endocarditis in a previously healthy non-drug user. Eur J Clin Microbiol Infect Dis (2002) 0.75
Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. Collaborative Famciclovir Genital Herpes Research Group. JAMA (1998) 2.69
Herpes simplex esophagitis in the immunocompetent patient: report of four cases and review. Clin Infect Dis (1992) 1.30
Acute bacterial meningitis in adults. A 12-year review. Medicine (Baltimore) (2000) 1.20
Uveitis and pseudojaundice during a regimen of clarithromycin, rifabutin, and ethambutol. MAC Study Group of the Canadian HIV Trials Network. N Engl J Med (1994) 0.99
A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex. Clin Infect Dis (1999) 0.89
A multicenter, open comparative study of parenteral cefotaxime and ceftriaxone in the treatment of nosocomial lower respiratory tract infections. Diagn Microbiol Infect Dis (1992) 0.86
Cross-resistance of Pseudomonas aeruginosa to ciprofloxacin, extended-spectrum beta-lactams, and aminoglycosides and susceptibility to antibiotic combinations. Antimicrob Agents Chemother (1989) 0.86
Isolated native tricuspid valve endocarditis caused by viridans streptococcus. Can J Infect Dis (2001) 0.85
Analysis of Mycobacterium avium complex isolates from blood samples of AIDS patients by pulsed-field gel electrophoresis. J Clin Microbiol (2003) 0.84
Polymicrobial endocarditis with eight pathogens in an intravenous drug abuser. Scand J Infect Dis (1990) 0.84
Appropriateness of metronidazole use in a teaching hospital. Am J Hosp Pharm (1989) 0.83
Branhamella catarrhalis bronchopulmonary isolates in PICU patients. Pediatr Pulmonol (1989) 0.83
Norfloxacin is inferior to chloroquine for falciparum malaria in northwestern Zambia: a comparative clinical trial. J Infect Dis (1992) 0.83
Estimating the effect of treatment on quality of life in the presence of missing data due to drop-out and death. Qual Life Res (1998) 0.82
In vitro activity of Sch 34343 and cefbuperazone against anaerobic bacteria. Antimicrob Agents Chemother (1985) 0.81
Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010). Canadian HIV Trials Network Protocol 010 Study Group. Int J STD AIDS (2000) 0.81
Comparison of dose doubling with probenecid for sustaining serum cefuroxime levels. J Antimicrob Chemother (1997) 0.81
Treatment of acute uncomplicated urinary tract infections with 3 days of lomefloxacin compared with treatment with 3 days of norfloxacin. Antimicrob Agents Chemother (1993) 0.81
Treatment of the chronic fatigue syndrome. A review and practical guide. Drugs (1993) 0.78
Cellulitis of the foot due to Eikenella corrodens. Arch Dermatol (1989) 0.78
Seroprevalence of HSV-1 and HSV-2 antibodies in Canadian women screened for enrolment in a herpes simplex virus vaccine trial. Int J STD AIDS (2013) 0.77
A multicenter phase I/II dose escalation study of single-dose cidofovir gel for treatment of recurrent genital herpes. Antimicrob Agents Chemother (1998) 0.77
Tuberculosis in children: what's new? CMAJ (1994) 0.75
Creutzfeldt-Jakob disease, new variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy - An update. Can J Infect Dis (1997) 0.75
Herpes simplex encephalitis. N Engl J Med (1996) 0.75
Opportunistic infections in HIV-infected patients. Can J Infect Dis (1992) 0.75
A syndromic approach to common parasitic diseases. CMAJ (1985) 0.75
Intravenous-to-oral conversion therapy for antimicrobials. Can J Infect Dis (1994) 0.75
The cost of health care for AIDS patients in Saskatchewan. Can J Infect Dis (1990) 0.75
Concomitant sarcoidosis and HIV infection. CMAJ (1990) 0.75
Clarithromycin prophylaxis for disseminated Mycobacterium avium complex infection--efficacy and acquired resistance. Clin Infect Dis (1998) 0.75
Dapsone- and primaquine-induced methemoglobinemia in HIV-infected individuals. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.75
Pharmacology and clinical experience with amprenavir. Expert Opin Investig Drugs (2000) 0.75
Does Chlamydia pneumoniae cause coronary atherosclerosis and should we all take macrolides? Can J Cardiol (1997) 0.75